![Richard Douglas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Douglas
Presidente presso ALDEYRA THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/05/2024
Posizioni attive di Richard Douglas
Società | Posizione | Inizio | Fine |
---|---|---|---|
IOMAI CORPORATION | Direttore/Membro del Consiglio | 01/01/2002 | - |
NOVAVAX, INC. | Direttore/Membro del Consiglio | 06/08/2010 | - |
Independent Dir/Board Member | 06/08/2010 | - | |
ALDEYRA THERAPEUTICS, INC. | Presidente | - | - |
Direttore/Membro del Consiglio | 13/09/2016 | - | |
Independent Dir/Board Member | 13/09/2016 | - | |
MAXCYTE, INC. | Independent Dir/Board Member | 12/02/2018 | - |
Presidente | 03/11/2021 | - | |
Direttore/Membro del Consiglio | 12/02/2018 | 03/11/2021 | |
Labyrinth Choir, Inc. | Direttore/Membro del Consiglio | - | - |
Helio Vision, Inc.
![]() Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Richard Douglas
Precedenti posizioni note di Richard Douglas
Società | Posizione | Inizio | Fine |
---|---|---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/1989 | 01/01/2011 |
Integrated Genetics, Inc.
![]() Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Corporate Officer/Principal | 01/01/1982 | 01/01/1989 |
Formazione di Richard Douglas
University of California, Berkeley | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Posizioni
Director/Board Member | 6 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 8 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
NOVAVAX, INC. | Health Technology |
ALDEYRA THERAPEUTICS, INC. | Health Technology |
MAXCYTE, INC. | Health Technology |
Aziende private | 5 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Intercell USA, Inc.
![]() Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
Integrated Genetics, Inc.
![]() Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Health Technology |
Labyrinth Choir, Inc. | |
Helio Vision, Inc.
![]() Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Richard Douglas
- Esperienza